Contrave - redOrbit

News - Contrave

OrexigenÂ® Therapeutics Presents Multiple ContraveÂ® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society

2011-10-03 07:00:00

SAN DIEGO, Oct. 3, 2011 /PRNewswire/ -- OrexigenÂ® Therapeutics, Inc.

OrexigenÂ® Therapeutics Announces Multiple ContraveÂ® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society

2011-09-29 07:00:00

SAN DIEGO, Sept. 29, 2011 /PRNewswire/ -- OrexigenÂ® Therapeutics, Inc.

FDA Reconsidering Weight-Loss Drug

FDA Reconsidering Weight-Loss Drug

2011-09-22 13:06:25

The FDA told Orexigen Therapeutics on Tuesday that it will reconsider the company's weight-loss drug Contrave.

Orexigen and FDA Identify a Clear and Feasible Path to Approval for ContraveÂ®

2011-09-20 15:00:00

SAN DIEGO, Sept. 20, 2011 /PRNewswire/ -- OrexigenÂ® Therapeutics, Inc.

OrexigenÂ® Therapeutics Announces Upcoming Data Presentations at The American College of Obstetricians and Gynecologists Annual Clinical Meeting

2011-04-26 07:01:00

SAN DIEGO, April 26, 2011 /PRNewswire/ -- OrexigenÂ® Therapeutics, Inc.

More News (62 articles) »

Videos - Contrave

Contrave New Obesity Drug Nears Market

Contrave: New Obesity Drug Nears Market

An Experimental Drug Could Help Obesity

An Experimental Drug Could Help Obesity

More Videos (2 videos) »